Stock-based Compensation Plans, Time Based Awards (Details)	1 Months Ended		3 Months Ended		12 Months Ended
	Aug. 31, 2016 USD ($) $ / shares shares	Feb. 29, 2016 USD ($) shares	Dec. 31, 2016 USD ($) Director Tranche $ / shares shares	Jan. 02, 2016 USD ($)	Sep. 30, 2016 USD ($) $ / shares shares
Stock Option Activity [Roll Forward]
Outstanding shares, exercised (in shares)			0
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of tranches | Tranche			2
Estimated fair value of stock at date of grant | $	$ 211,000
Share based compensation expense | $			$ 30,584	$ 0
Vested options exercisable (in shares)			12,165
Period for vested options exercisable			3 months
Number of Shares of Stock Options [Roll Forward]
Non-vested balance, beginning of period (in shares)			50,625
Non-vested balance, end of period (in shares)			50,625		50,625
Weighted Average Grant-Date Fair Value [Abstract]
Non-vested balance, beginning of period (in dollars per share) | $ / shares			$ 4.67
Non-vested balance, ending of period (in dollars per share) | $ / shares			$ 4.67		$ 4.67
Stock Options [Member] | First Tranche [Member]
Stock Option Activity [Roll Forward]
Outstanding shares, granted (in shares)	36,496
Weighted Average Exercise Price [Abstract]
Weighted average exercise price, exercised (in dollars per share) | $ / shares	$ 10.93
Stock Options [Member] | Second Tranche [Member]
Stock Option Activity [Roll Forward]
Outstanding shares, granted (in shares)	20,204
Weighted Average Exercise Price [Abstract]
Weighted average exercise price, exercised (in dollars per share) | $ / shares	$ 12.35
Stock Options [Member] | Executive Chairman [Member]
Stock Option Activity [Roll Forward]
Outstanding shares, granted (in shares)	56,700
Time Based Awards [Member]
Stock Option Activity [Roll Forward]
Outstanding shares, beginning balance (in shares)			12,165
Outstanding shares, granted (in shares)			0
Outstanding shares, exercised (in shares)			0
Outstanding shares, forfeited or expired (in shares)			0
Outstanding shares, ending balance (in shares)			12,165		12,165
Outstanding shares, exercisable (in shares)			0
Outstanding shares, vested (in shares)			12,165
Weighted Average Exercise Price [Abstract]
Weighted average exercise price, beginning balance (in dollars per share) | $ / shares			$ 10.93
Weighted average exercise price, granted (in dollars per share) | $ / shares			0
Weighted average exercise price, exercised (in dollars per share) | $ / shares			0
Weighted average exercise price, forfeited or expired (in dollars per share) | $ / shares			0
Weighted average exercise price, ending balance (in dollars per share) | $ / shares			10.93		$ 10.93
Weighted average exercise price, exercisable (in dollars per share) | $ / shares			0
Weighted average exercise price, vested (in dollars per share) | $ / shares			$ 10.93
Weighted Average Remaining Contractual Term (Years) [Abstract]
Weighted average remaining contractual term			3 years 8 months 1 day		4 years 29 days
Weighted average remaining contractual term, granted			0 years
Weighted average remaining contractual term, exercised			0 years
Weighted average remaining contractual term, forfeited or expired			0 years
Weighted average remaining contractual term, exercisable			0 years
Weighted average remaining contractual term, vested			3 years 8 months 1 day
Aggregate Intrinsic Value [Abstract]
Aggregate intrinsic value, beginning balance | $			$ 0
Aggregate intrinsic value, granted | $			0
Aggregate intrinsic value, exercised | $			0
Aggregate intrinsic value, forfeited or expired | $			0
Aggregate intrinsic value, ending balance | $			0		$ 0
Aggregate intrinsic value, exercisable | $			0
Aggregate intrinsic value, vested | $			$ 0
Restricted Stock [Member]
Number of shares of Restricted Stock [Roll Forward]
Non-vested balance, beginning of period (in shares)			138,940
Vested (in shares)			(60,000)
Non-vested balance, end of period (in shares)			78,940		138,940
Weighted Average Grant-Date Fair Value [Roll Forward]
Non-vested balance, beginning of period (in dollars per share) | $ / shares			$ 6.50
Vested (in dollars per share) | $ / shares			6.39
Non-vested balance, ending of period (in dollars per share) | $ / shares			$ 6.58		$ 6.50
Restricted Stock [Member] | Nine Non-Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of employees directors with restricted stock grant | Director			9
Estimated fair value of stock at date of grant | $		$ 292,000
Period for recognition of unearned compensation			12 months
Number of shares of cancelled (in shares)		(3,300)
Share based compensation expense | $			$ 64,812	$ 0
Stock Option Activity [Roll Forward]
Outstanding shares, granted (in shares)		29,700